Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.

[1]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Tanaka,et al.  Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets. , 1989, Bone and mineral.

[3]  M. Haussler,et al.  Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. , 1988, Endocrinology.

[4]  H. Tanaka,et al.  Effects of the administration of phosphate on nuclear 1,25-dihydroxyvitamin D3 uptake by duodenal mucosal cells of Hyp mice. , 1988, Endocrinology.

[5]  R. Morris,et al.  Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. , 1987, The Journal of clinical investigation.

[6]  Y. Seino,et al.  Decreased nuclear uptake of 1,25-dihydroxyvitamin D3 by duodenal mucosal cells in the X-linked hypophosphatemic mouse. , 1985, Endocrinology.

[7]  Z. Hochberg,et al.  Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. , 1985, The Journal of clinical investigation.

[8]  J. Adams,et al.  Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. , 1984, The Journal of clinical endocrinology and metabolism.

[9]  S. Krane,et al.  Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. , 1983, The Journal of clinical endocrinology and metabolism.

[10]  S. Manolagas,et al.  1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.

[11]  M. Drezner,et al.  Abnormal regulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the X-linked hypophosphatemic mouse. , 1983, The Journal of clinical investigation.

[12]  L. Avioli,et al.  lα, 25-DIHYDROXYVITAMIN D3 RECEPTOR IN THE X-LINKED HYPOPHOSPHATEMIC MOUSE. , 1982 .

[13]  F. Glorieux,et al.  X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. , 1981, The Journal of clinical endocrinology and metabolism.

[14]  M. Haussler,et al.  Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. , 1980, The Journal of clinical investigation.

[15]  F. Glorieux,et al.  Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. , 1980, The New England journal of medicine.

[16]  Y. Seino,et al.  Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood. , 1980, Archives of disease in childhood.

[17]  H. DeLuca,et al.  Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid. , 1978, Pediatrics.

[18]  F. Glorieux,et al.  Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Norman,et al.  Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets. , 1973, The New England journal of medicine.

[20]  F. Glorieux,et al.  Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. , 1972, The New England journal of medicine.

[21]  F. Glorieux,et al.  Loss of a Parathyroid Hormone-Sensitive Component of Phosphate Transport in X-Linked Hypophosphatemia , 1972, Science.

[22]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[23]  F. Albright,et al.  Rickets resistant to vitamin D therapy. , 1937 .

[24]  S. Iacobelli,et al.  Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia. , 1987, Oncology.

[25]  M. Haussler,et al.  Abnormal relationship between serum phosphate concentration and renal 25-hydroxycholecalciferol-1-alpha-hydroxylase activity in X-linked hypophosphatemic mice. , 1986, Mineral and electrolyte metabolism.

[26]  Y. Seino,et al.  PLASMA CLEARANCE FOR HIGH DOSES OF EXOGENOUS 1,25-DIHYDROXY[23,24(n)- 3 H]CHOLECALCIFEROL IN X-LINKED HYPOPHOSPHATEMIC MICE , 1982 .

[27]  Y. Seino,et al.  Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets. , 1980, Contributions to nephrology.

[28]  Y. Seino,et al.  Competitive protein binding assay for plasma 25-hydroxycholecalciferol. , 1980, Methods in enzymology.